Hepatic Mitochondrial Beta-Oxidation in Patients With Nonalcoholic Steatohepatitis Assessed by 13C-Octanoate Breath Test

2003/10/01 by Luca Miele, Antonio Grieco, Alessandro Armuzzi +4 · 28 citations
Medicine · #BETA (programming language) #Breath test #Diet and metabolism studies #Disease #Fatty liver #Gastroenterology #Internal medicine #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation #Medicine #Nonalcoholic fatty liver disease #Nonalcoholic steatohepatitis #Steatohepatitis

paper · doi:10.1111/j.1572-0241.2003.07725.x

openalex publication_date 2003/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/26

Abstract

Miele, Luca MD; Grieco, Antonio MD; Armuzzi, Alessandro MD; Candelli, Marcello MD; Forgione, Alessandra MD; Gasbarrini, Antonio MD; Gasbarrini, Giovanni MD Author Information

Cited by

• Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
• Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
• Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
• N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. [europepmc]
• Apoptosis and cytokines in non-alcoholic steatohepatitis. [europepmc]
• Mitochondria and redox signaling in steatohepatitis. [europepmc]
• Treatment options for nonalcoholic fatty liver disease. [europepmc]
• Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis. [europepmc]
• Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess. [europepmc]
• Mitochondrial morphology in metabolic diseases. [europepmc]
• Mitochondrial fatty acid oxidation in obesity. [europepmc]
• Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. [europepmc]
• Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. [europepmc]
• Pathogenesis of nonalcoholic steatohepatitis. [europepmc]
• Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. [europepmc]
• Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. [europepmc]
• Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease. [europepmc]
• Mitochondrial Dysfunction in the Transition from NASH to HCC. [europepmc]
• miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1. [europepmc]
• MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. [europepmc]
• Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression. [europepmc]
• Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? [europepmc]
• Targeting Mitochondria in Diabetes. [europepmc]
• Metabolic Changes of Hepatocytes in NAFLD. [europepmc]
• Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. [europepmc]
• Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease. [europepmc]
• Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). [europepmc]
• Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. [europepmc]

Related

• A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
• Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
• The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
• Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis
• Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease